RHYTHM PHARMACEUTICALS, INC.
RYTM
43 insider filings · Latest: Sep 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Feb 20 2:02 AM | Hunter C SmithChief Financial Officer | Sale | 4,385 | $101.26 | $444.0K | 110,512(D) | View → |
| Feb 17, 2026 | Feb 20 2:02 AM | Hunter C SmithChief Financial Officer | Sale | 3,569 | $101.38 | $361.8K | 114,897(D) | View → |
| Feb 12, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Sale | 1,592 | $98.23 | $156.4K | 118,466(D) | View → |
| Feb 11, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Sale | 2,766 | $98.61 | $272.8K | 120,058(D) | View → |
| Feb 10, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Sale | 2,713 | $103.00 | $279.4K | 122,824(D) | View → |
| Feb 5, 2026 | Feb 6 11:38 PM | Hunter C SmithChief Financial Officer | Sale | 3,381 | $106.06 | $358.6K | 125,537(D) | View → |
| Feb 4, 2026 | Feb 6 11:38 PM | Hunter C SmithChief Financial Officer | Sale | 3,247 | $105.99 | $344.1K | 128,918(D) | View → |
| Feb 5, 2026 | Feb 5 9:30 PM | HUNTER SMITH | Proposed Sale | 18,406 | $107.97 | $2.0M | — | View → |
| Feb 4, 2026 | Feb 4 9:21 PM | HUNTER SMITH | Proposed Sale | 3,247 | $108.29 | $351.6K | — | View → |
| Dec 11, 2025 | Dec 11 9:25 PM | PAMELA CRAMER | Proposed Sale | 3,350 | $104.77 | $351.0K | — | View → |
| Nov 20, 2025 | Nov 20 9:23 PM | PAMELA CRAMER | Proposed Sale | 3,350 | $103.15 | $345.6K | — | View → |
| Nov 10, 2025 | Nov 10 9:31 PM | PAMELA CRAMER | Proposed Sale | 3,515 | $100.30 | $352.6K | — | View → |
| Nov 7, 2025 | Nov 7 9:38 PM | PAMELA CRAMER | Proposed Sale | 19,351 | $98.49 | $1.9M | — | View → |
| Oct 30, 2025 | Oct 30 8:16 PM | JOSEPH SHULMAN | Proposed Sale | 9,748 | $113.89 | $1.1M | — | View → |
| Oct 28, 2025 | Oct 28 8:17 PM | JOSEPH SHULMAN | Proposed Sale | 2,815 | $111.55 | $314.0K | — | View → |
| Oct 16, 2025 | Oct 16 8:20 PM | JOSEPH SHULMAN | Proposed Sale | 14,437 | $109.35 | $1.6M | — | View → |
| Sep 2, 2025 | Sep 2 8:41 PM | JOSEPH SHULMAN | Proposed Sale | 16,781 | $103.15 | $1.7M | — | View → |
| Aug 21, 2025 | Aug 21 8:45 PM | JOSEPH SHULMAN | Proposed Sale | 4,188 | $98.70 | $413.4K | — | View → |
| Aug 12, 2025 | Aug 12 8:28 PM | HUNTER SMITH | Proposed Sale | 28,088 | $94.31 | $2.6M | — | View → |
| Aug 12, 2025 | Aug 12 8:26 PM | CHRISTOPHER PAUL GERMAN | Proposed Sale | 1,500 | $94.31 | $141.5K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 3 9:36 PM | Yann MazabraudEVP, Head of International | Option Exercise | 12,875 | — | 5,000(D) | View → |
| Apr 1, 2026 | Apr 3 9:35 PM | Kimberly J PopovitsDirector | Grant/Award | 17,065 | $88.12 | 10,257(D) | View → |
| Mar 4, 2026 | Mar 6 9:51 PM | Christopher Paul GermanCorporate Controller & CAO | Option Exercise | 1,500 | $17.97 | 3,731(D) | View → |
| Mar 2, 2026 | Mar 5 1:22 AM | Yann MazabraudEVP, Head of International | Grant/Award | 35,000 | $94.94 | 35,000(D) | View → |
| Mar 1, 2026 | Mar 4 12:45 AM | Christopher Paul GermanCorporate Controller & CAO | Option Exercise | 1,162 | — | 1,162(D) | View → |
| Mar 2, 2026 | Mar 3 1:56 AM | Hunter C SmithChief Financial Officer | Option Exercise | 6,099 | $6.80 | 91,401(D) | View → |
| Feb 14, 2026 | Feb 18 9:30 PM | Yann MazabraudEVP, Head of International | Option Exercise | 10,000 | — | 30,000(D) | View → |
| Feb 11, 2026 | Feb 13 10:53 PM | Joseph ShulmanChief Technical Officer | Grant/Award | 37,500 | $98.47 | 22,500(D) | View → |
| Feb 11, 2026 | Feb 13 10:52 PM | David P MeekerDirector, President and CEO | Grant/Award | 179,750 | $98.47 | 107,850(D) | View → |
| Feb 11, 2026 | Feb 13 10:50 PM | Yann MazabraudEVP, Head of International | Grant/Award | 23,350 | — | 23,350(D) | View → |
| Feb 11, 2026 | Feb 13 10:49 PM | Jennifer Kayden LeeEVP, Head of North America | Grant/Award | 54,150 | $98.47 | 32,500(D) | View → |
| Feb 11, 2026 | Feb 13 10:48 PM | Christopher Paul GermanCorporate Controller & CAO | Grant/Award | 5,215 | — | 5,215(D) | View → |
| Feb 11, 2026 | Feb 13 10:47 PM | Alastair GarfieldChief Scientific Officer | Grant/Award | 41,650 | $98.47 | 25,000(D) | View → |
| Feb 11, 2026 | Feb 13 10:45 PM | Pamela J. CramerChief Human Resources Officer | Grant/Award | 29,150 | $98.47 | 17,500(D) | View → |
| Feb 11, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Grant/Award | 62,500 | $98.47 | 37,500(D) | View → |
| Feb 1, 2026 | Feb 3 9:38 PM | Yann MazabraudEVP, Head of International | Option Exercise | 5,500 | — | 11,000(D) | View → |
| Feb 1, 2026 | Feb 3 9:36 PM | Hunter C SmithChief Financial Officer | Option Exercise | 26,000 | — | 31,237(D) | View → |
| Feb 1, 2026 | Feb 3 9:35 PM | Joseph ShulmanChief Technical Officer | Option Exercise | 16,968 | — | 18,750(D) | View → |
| Feb 1, 2026 | Feb 3 9:34 PM | David P MeekerDirector, President and CEO | Option Exercise | 68,713 | — | 100,012(D) | View → |
| Feb 1, 2026 | Feb 3 9:33 PM | Jennifer Kayden LeeEVP, Head of North America | Option Exercise | 22,612 | — | 27,487(D) | View → |